Patents by Inventor Ettore Novellino

Ettore Novellino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148815
    Abstract: The present invention describes a gastro-resistant pharmaceutical/nutraceutical composition comprising chincona cortex freeze-dried (Cinchona succirubra), chicory leaves and roots freeze-dried (Cichorium intybus, and/or Cichorium endivia, and/or Cichorium pumilum, and/or Cichorium spinosum), and gentian root freeze-dried (Gentiana lutea), and optionally griffonia seed extract (Griffonia simplicifolia). The nutraceutical composition object of the present invention is useful for appetite control, mealtime energy intake reduction, and body weight loss.
    Type: Application
    Filed: March 8, 2022
    Publication date: May 9, 2024
    Inventors: Ettore Novellino, Gian Carlo Tenore
  • Patent number: 10689342
    Abstract: Object of the present invention are new aza-tanshinone derivatives, a method for their preparation and their use in therapy, particularly, but not limited to, as anti-tumor agents and anti-inflammatories. The invention comprises also the pharmaceutical compositions containing them.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: June 23, 2020
    Assignee: UNIVERSITA' DEGLI STUDI DI TRENTO
    Inventors: Alessandro Provenzani, Vito Giuseppe D'Agostino, Natthakan Thongon, Chiara Zucal, Preet Lal, Valentina Adami, Pierfausto Seneci, Leonardo Manzoni, Luciana Marinelli, Ettore Novellino, Marco Fragai, Claudio Luchinat, Linda Cerofolini, Carmelo Fuccio
  • Publication number: 20190241516
    Abstract: Object of the present invention are new aza-tanshinone derivatives, a method for their preparation and their use in therapy, particularly, but not limited to, as anti-tumor agents and anti-inflammatories. The invention comprises also the pharmaceutical compositions containing them.
    Type: Application
    Filed: June 14, 2017
    Publication date: August 8, 2019
    Inventors: Alessandro PROVENZANI, Vito Giuseppe D'AGOSTINO, Natthakan THONGON, Chiara ZUCAL, Preet LAL, Valentina ADAMI, Pierfausto SENECI, Leonardo MANZONI, Luciana MARINELLI, Ettore NOVELLINO, Marco FRAGAI, Claudio LUCHINAT, Linda CEROFOLINI, Carmelo FUCCIO
  • Publication number: 20150330983
    Abstract: The use of opportunely modified specific ligands of the receptor for urotensin II (UTR) or antibodies (commercially available) raised against the same receptor as tools for the definition of both the differentiation and the prognosis of human prostate adenocarcinoma is described, moreover, the use of opportunely radiolabeled ligands for UTR in the definition of the extension of disease is also described.
    Type: Application
    Filed: December 9, 2013
    Publication date: November 19, 2015
    Inventors: Ettore NOVELLINO, Paolo GRIECO, Michele CARAGLIA, Alfredo BUDILLON, Renato FRANCO, Santolo Rosaria ADDEO
  • Patent number: 8513381
    Abstract: The present invention finds application in the therapeutic fields. In particular, it concerns new synthetic melanocortin peptides having improved antimicrobial activity.
    Type: Grant
    Filed: January 19, 2009
    Date of Patent: August 20, 2013
    Assignee: Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico
    Inventors: Anna Catania, Ferruccio Bonino, Paolo Grieco, Ettore Novellino
  • Publication number: 20120015873
    Abstract: The present invention finds application in the therapeutic fields. In particular, it concerns new synthetic melanocortin peptides having improved antimicrobial activity.
    Type: Application
    Filed: January 19, 2009
    Publication date: January 19, 2012
    Inventors: Anna Catania, Ferruccio Bonino, Paolo Grieco, Ettore Novellino
  • Publication number: 20100099604
    Abstract: The use of opportunely modified specific ligands of the receptor for urotensin II (UTR) or antibodies (commercially available) raised against the same receptor as tools for the definition of both the differentiation and the prognosis of human prostate adenocarcinoma is described, moreover, the use of opportunely radiolabeled ligands for UTR in the definition of the extension of disease is also described.
    Type: Application
    Filed: February 8, 2008
    Publication date: April 22, 2010
    Inventors: Ettore Novellino, Paolo Grieco, Michele Caraglia, Alfredo Budillon, Renato Franco, Santolo Rosario Addeo
  • Publication number: 20090098208
    Abstract: The present invention relates to pharmaceutical compositions for the oral administration of pharmacologically active molecules, comprising a release means consisting of porous zeolite in powder form, incorporating pharmacologically active molecules inside the pores and/or on its surface, the relative use for the preparation of drugs for oral administration, in particular for the treatment of inflammatory pathologies at an intestinal level and the preparation process of these compositions.
    Type: Application
    Filed: October 6, 2008
    Publication date: April 16, 2009
    Applicant: SASOL ITALY S.p.A.
    Inventors: Maria Grazia RIMOLI, Maria Roberta Rabaioli, Enrico Abignente, Daniela Melisi, Rosella Mirabelli, Ettore Novellino, Annalisa Curcio, Salvatore De Lucia, Alessandro Nasti
  • Publication number: 20080249080
    Abstract: The invention concerns benzodiazepine derivatives of formula wherein Y it is SO2 or NR, wherein R is H or C1-C6 alkyl; X is H, C1-C12 alkyl, —CO, —SO, —SO2, or —CO—R2, SO—R2, SO2—R2, wherein R2 is selected from H, C1-C12 alkyl, (C3-C8 cycloalkyl) C0-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C2-C6 alkoxycarbonyl, phenyl, benzyl, naphtyl, biphenyl, or heterocycle, each para-, meta- or ortho-substituted independently of each other with 0 to 3 substituents selected from halogen, —CN, —NH2, —OH, —NO2, COOR3, wherein R3 is selected from H, C1-C12 alkyl, (C3-C8 cycloalkyl) C0-C6 alkyl, C1-C6 alkoxy, C2-C6 alkenyl, C2-C6 alkynyl, or C2-C6 alkoxy carbonyl; phenyl, benzyl, naphtyl, biphenyl, or heterocycle n is 0-6; R4 is selected from H, OH, COOH, CN, C1-C6 alkyl, C1-C6 alkoxy, C2-C6 alkenyl, C2-C6 alkynyl, C2-C6 alkoxycarbonyl, —CO, —SO, —SO2, or —CO—R5, SO—R5, SO2—R2, —OCO—R5, OSO—R5, SO2—R5, COOR5, SOOR5, SO2OR5, NHR5, NHCOR5, NHSO2R5, SR5, SCOR5, wherein R5 is selected from H, C1-C6 alkyl, C1-C6 alkoxy, C2-C6
    Type: Application
    Filed: May 26, 2006
    Publication date: October 9, 2008
    Inventors: Romano Silvestri, Gabriella Marfe', Elisabetta Abruzzese, Gianfranco Catalano, Carla Di Stefano, Ettore Novellino, Paola Sinibaldi Salimei, Maria Gabriella De Martino, Giuseppe La Regina, Antonio La-Vecchia